ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

KMDA Kamada Ltd

5.61
0.01 (0.18%)
Mar 28 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 13,869
Bid Price 5.50
Ask Price 7.09
News -
Day High 5.67

Low
4.08

52 Week Range

High
6.5291

Day Low 5.59
Company Name Stock Ticker Symbol Market Type
Kamada Ltd KMDA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.01 0.18% 5.61 20:00:00
Open Price Low Price High Price Close Price Prev Close
5.61 5.59 5.67 5.61 5.60
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
149 13,869 $ 5.64 $ 78,176 - 4.08 - 6.5291
Last Trade Time Type Quantity Stock Price Currency
16:00:00 1,406 $ 5.61 USD

Kamada Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
324.15M 57.47M - 142.52M 8.28M 0.14 39.14
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Kamada News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No KMDA Message Board. Create One! See More Posts on KMDA Message Board See More Message Board Posts

Historical KMDA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week5.915.915.575.7017,644-0.30-5.08%
1 Month6.376.52915.565.9527,651-0.76-11.93%
3 Months6.126.52915.565.9323,714-0.51-8.33%
6 Months5.196.52914.085.6845,4560.428.09%
1 Year4.606.52914.085.4838,2111.0121.96%
3 Years6.066.963.7215.4641,882-0.45-7.43%
5 Years5.7813.333.7217.3087,659-0.17-2.94%

Kamada Description

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Your Recent History

Delayed Upgrade Clock